Amdocs Limited Earnings

Amdocs Limited’s revenue jumped 1.5% since last year same period to $1263.88Mn in the Q3 2024. On a quarterly growth basis, Amdocs Limited has generated 1.11% jump in its revenue since last 3-months.

Amdocs Limited’s net profit fell -41.58% since last year same period to $86.44Mn in the Q3 2024. On a quarterly growth basis, Amdocs Limited has generated -38.38% fall in its net profits since last 3-months.

Amdocs Limited’s net profit margin fell -42.44% since last year same period to 6.84% in the Q3 2024. On a quarterly growth basis, Amdocs Limited has generated -39.06% fall in its net profit margins since last 3-months.

Amdocs Limited’s price-to-earnings ratio after this Q3 2024 earnings stands at 20.44.

Amdocs Limited’s earning per share (EPS) estimates for the current quarter stand at 1.7 - a 6.25% jump from last quarter’s estimates.

Amdocs Limited’s earning per share (EPS) estimates for the current year stand at 1.7.

Amdocs Limited’s earning per share (EPS) jumped 19.72% since last year same period to 1.7 in the Q3 2024. This indicates that the Amdocs Limited has generated 19.72% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Amdocs Limited’s return on assets (ROA) stands at 0.07.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Amdocs Limited’s return on equity (ROE) stands at 0.14.

Amdocs Limited declared 0.48 dividend per share during the earnings announcement for Q3 2024.